Shanghai - Delayed Quote CNY

Shaanxi Meibang Pharmaceutical Group Co., Ltd. (605033.SS)

16.97
+0.55
+(3.35%)
At close: 3:00:04 PM GMT+8
Currency in CNY All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
862,852.82
885,528.32
699,026.90
906,045.60
842,490.33
Cost of Revenue
612,034.05
632,740.83
459,927.38
518,855.17
520,062.27
Gross Profit
250,818.77
252,787.49
239,099.52
387,190.43
322,428.06
Operating Expense
233,117.23
215,643.12
179,161.99
236,669.44
183,406.25
Operating Income
17,701.54
37,144.36
59,937.54
150,520.99
139,021.81
Net Non Operating Interest Income Expense
1,135.70
1,416.73
1,489.67
1,657.69
-1,730.47
Pretax Income
19,397.06
37,858.33
62,410.21
152,367.55
138,830.98
Tax Provision
-2,976.32
999.06
4,853.21
7,279.23
13,088.09
Net Income Common Stockholders
22,373.38
36,859.27
57,557
145,088.33
125,742.88
Basic EPS
0.16
0.27
0.43
1.07
1.14
Diluted EPS
0.16
0.27
0.43
1.07
1.14
Basic Average Shares
136,887.22
136,515.81
133,853.50
135,596.57
110,300.77
Diluted Average Shares
136,887.22
136,515.81
133,853.50
135,596.57
110,300.77
Total Operating Income as Reported
11,069.07
30,642.16
50,367.97
140,273.36
122,503.54
Total Expenses
845,151.28
848,383.96
639,089.37
755,524.61
703,468.52
Net Income from Continuing & Discontinued Operation
22,373.38
36,859.27
57,557
145,088.33
125,742.88
Normalized Income
31,565.03
52,139.02
71,983.65
160,339.42
140,012.68
Interest Income
1,335.35
1,574.31
1,996.54
2,749.76
1,702.63
Interest Expense
--
9.48
375.41
979.49
3,307.12
Net Interest Income
1,135.70
1,416.73
1,489.67
1,657.69
-1,730.47
EBIT
23,853.72
37,867.81
62,785.63
153,347.04
142,138.09
EBITDA
23,853.72
59,615.38
83,656.35
168,819.97
154,615.68
Reconciled Cost of Revenue
612,034.05
632,740.83
459,927.38
518,855.17
520,062.27
Reconciled Depreciation
--
21,747.57
20,870.72
15,472.93
12,477.59
Net Income from Continuing Operation Net Minority Interest
22,373.38
36,859.27
57,557
145,088.33
125,742.88
Total Unusual Items Excluding Goodwill
-15,319.41
-15,693.91
-15,643.10
-16,016.26
-15,755.08
Total Unusual Items
-15,319.41
-15,693.91
-15,643.10
-16,016.26
-15,755.08
Normalized EBITDA
39,173.13
75,309.29
99,299.45
184,836.23
170,370.76
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-6,127.76
-414.15
-1,216.46
-765.16
-1,485.29
12/31/2021 - 9/16/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers